Clinical Trial Update: STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism [Phase 3]

View source ↗

Summary

Phase 3 trial update on stopping anticoagulation for isolated or incidental subsegmental pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subsegmental Pulmonary Embolism

Snippet

Sponsor: University of Birmingham | Conditions: Subsegmental Pulmonary Embolism Nos | Phase 3 | Status: UNKNOWN